Ocular Pharmacokinetic Study Following Single and Multiple Azithromycin Administrations in Pigmented Rabbits

REFERENCES

• Jaruratanasirikul S, Hortiwakul R, Tantisarasart T, Phuenpathom N, Tussanasunthornwong S. Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. Antimicrob Agents Chemother. 1996; 40: 825–826
   PubMed Web of Science ®Google Scholar
• Retsema J, Girard A, Schelldy W, Manousos M, Anderson M, Bright G, Borovoy R, Brennan L, Mason R. Spectrum and mode of action of azithromycin (CP-62, 993), a 15-membered ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother 1987; 31: 1939–1947
   PubMed Web of Science ®Google Scholar
• Wyrick P B, Davis C H, Knight S T, Choong J. In vitro activity of azithromycin on Chlamydia trachomatis infected, polarized human endometrial cells. J Antimicrob Chemother. 1993; 31: 139–150
   PubMed Web of Science ®Google Scholar
• Tabbara K F, al-Kharashi S A, al-Mansouri S M, al-Omar O M, Cooper H, el-Asrar A M, Foulds G. Ocular levels of azithromycin. Arch Ophthalmol. 1998; 116: 1625–1628
   PubMedGoogle Scholar
• Bowman R JC, Sillah A, van Dehn C, Goode V M, Muquit M, Johnson G J, Milligan P, Rowley J, Faal H, Bailey R L. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Invest Ophthalmol Vis Sci. 2000; 41: 4074–4079
   PubMed Web of Science ®Google Scholar
• Bailey R L, Arullendran P, Whittle H C, Mabey D C. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 1993; 342: 453–456
   PubMed Web of Science ®Google Scholar
• Chem K C, Shrestha S K, Cevallos V, Dhami H L, Tiwari P, Chem L, Whitcher J P, Lietman T M. Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area. Br J Ophthalmol 1999; 83: 1332–1335
   PubMed Web of Science ®Google Scholar
• Scieux C, Bianchi A, Chappey B, Vassias I, Perol Y. In vitro activity of azithromycin against Chlamydia trachomatis. J Antimicrob Chemother 1990; 25: 7–10, (Suppl A)
   PubMed Web of Science ®Google Scholar
• Slaney L, Chubb H, Ronald A, Brunham R. In vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi Chlamydia trachomatis. J Antimicrob Chemother 1990; 25: 1–5, (Suppl A)
   PubMed Web of Science ®Google Scholar
• Drew R H, Gallis H A. Azithromycin-spectrum of activity, pharmacokinetics, and clinical applications. Pharmacotherapy. 1992; 12: 161–173
   PubMed Web of Science ®Google Scholar
• Fechner P U, Teichmann K D. Chemotherapy of bacterial infections. Ocular therapeutics. Pharmacology and Clinical Application, P U Fechner, K D Teichmann. Slack Incorporated, Thorofare, NJ 1998; 2: 15–44
   Google Scholar
• Barry A L, Jones R N, Thornsberry C. In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-0.31), erythromycin, roxithromycin, and clindamycin. Antimicrob Agents Chemother. 1998; 32: 752–754
   Google Scholar
• Retsema J, Girard A, Schelkly W, Manousos M, Anderson M, Bright G, Borovoy R, Brennan L, Mason R. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother. 1987; 31: 1939–1947
   PubMed Web of Science ®Google Scholar
• Peters D H, Friedel H A, McTavish D. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 1992; 44: 750–799
   PubMed Web of Science ®Google Scholar
• Carbon C, Poole M D. The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data. J Chemother 1999; 11: 107–118
   PubMed Web of Science ®Google Scholar
• Barry A L, Fuchs P C, Brown S D. Macrolide resistance among Streptococcus pneumoniae Streptococcus pyogenes isolates from out-patients in the USA. J Antimicrob Chemother 1997; 40: 139–140
   PubMed Web of Science ®Google Scholar
• Zuckerman J M. Macolides and ketolides: Azithromycin, clarithromycin, telithromycin. Infect Dis Clin North Am. 2004; 18: 621–649
   PubMed Web of Science ®Google Scholar
• Thomson K S, Chartrand S A, Sanders C C, Block S. Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus peumoniae. Antimicrob Agents Chemother 1997; 41: 478–480
   PubMed Web of Science ®Google Scholar
• Morrow G L, Abbott R L. Conjunctivitis. Am Fam Physician. 1998; 57: 735–746
   PubMed Web of Science ®Google Scholar
• Soukiasian S H, Baum J. Bacterial conjunctivitis. Cornea, 2nd Edition, J H Krachmer, M J Mannis, E J Holland. Elsevier Mosby, Philadelphia, PA 2005; 615–628
   Google Scholar
• Syed N A, Chandler J W. Bacterial conjunctivitis. Infections of the Eye, K F Tabbara, R A Hyndiuk. Little, Brown and Co, Boston, MA 1996; 423–431
   Google Scholar
• Ben Ali F, Golstein F W, Acar J F. In vitro activity of macrolides against traditional susceptible bacteria. Macrolide Antibiotics, W Schonfeld, H A Kirst. Birkhaüse Verlag, BaselSwitzerland 2002; 185–200
   Google Scholar
• Gigliotti F, Williams W T, Hayden F G, Hendley J O, Benjamin J, Dickens M, Gleason C, Perriello V A, Wood J. Etiology of acute conjunctivitis in children. J Pediatr. 1981; 98: 531–536
   PubMed Web of Science ®Google Scholar
• Gross R D, Hoffman R O, Lindsay R N. A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children. Clin Pediatr (Phila). 1997; 36: 435–444
   PubMed Web of Science ®Google Scholar
• World Health Organization, Report of the First Meeting of the WHO Alliance for the Global Elimination of Trachoma. Geneva, Switzerland, 30 June–1 July 1997; WHO/PBL/GET/97: 1–33
   Google Scholar
• O'Day D, Head W S, Foulds G, Robinson R D, Williams T E, Ferraina R A. Ocular pharmacokinetics of orally administered azithromycin in rabbits. J Ocular Pharmacol. 1994; 10: 633–641
   PubMedGoogle Scholar
• Karcioglu Z A, Ahmed W S, Raines D, Al-Yazigi A. Pharmacokinetics of azithromycin in rabbit lacrimal glands and conjunctiva. Ophthalmic Res 1999; 31: 47–52
   PubMed Web of Science ®Google Scholar
• Tabbara K F, El-Asrar A MA, Al-Omar O, Choudhury A H, al-Faisal Z. Single-dose azithromycin in the treatment of trachoma. Ophthalmology. 1996; 103: 842–846
   PubMed Web of Science ®Google Scholar